Russia’s General Prosecutor Office to force producers to reduce prices for vital drugs

The Russian General Prosecutor Office and the Federal Antimonopoly Service (FAS) have initiated a new wave of massive checks of national pharmacies and pharmaceutical producers, which are suspected of being responsible for a significant increase of prices for their products, reports The Pharma letter’s local correspondent.

So far, the Russian law enforcement agencies have already received up to 300 complaints about the increase of prices for such common drugs as validol, corvalol, metformin, indapamide by more than three times. It is planned that checks will affect Russia’s leading pharmacies, such as Gorzdrav, Rigla, Serdechko, Norma and some others.

According to an official spokesman of General Prosecutor Office, particular attention will be paid to the tightening of control for drugs from the list of vital medicines, prices for some of which have increased by almost 10 times.